Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma - Wikidata - wikimedia - TriplyDB

Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma

Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma

http://www.wikidata.org/entity/Q35634469

about

RECENT ADVANCES IN ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR THE ANALYSIS OF TRADITIONAL CHINESE MEDICINE.American ginseng (Panax quinquefolius) administration does not affect performance of the Roche COBAS Ampliprep/Taqman HIV-1 RNA assay.Commonly Used Dietary Supplements on Coagulation Function during Surgery Paraptosis and NF-κB activation are associated with protopanaxadiol-induced cancer chemoprevention Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract.Qualitative and Quantitative Analysis of the Major Constituents in Shexiang Tongxin Dropping Pill by HPLC-Q-TOF-MS/MS and UPLC-QqQ-MS/MS.Analysis of Panax notoginseng metabolites in rat bile by liquid chromatography-quadrupole time-of-flight mass spectrometry with microdialysis sampling.Serum Pharmacochemistry Analysis Using UPLC-Q-TOF/MS after Oral Administration to Rats of Shenfu Decoction.Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota.Herbal medicines as adjuvants for cancer therapeutics.Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions Determination of American ginseng saponins and their metabolites in human plasma, urine and feces samples by liquid chromatography coupled with quadrupole time-of-flight mass spectrometry Identification of Human UDP-Glucuronosyltransferase 1A4 as the Major Isozyme Responsible for the Glucuronidation of 20(S)-Protopanaxadiol in Human Liver Microsomes.Pharmacodynamics of ginsenosides: antioxidant activities, activation of Nrf2, and potential synergistic effects of combinations.Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application.Enhanced Absorption Study of Ginsenoside Compound K (20-O-β-(D-Glucopyranosyl)-20(S)-protopanaxadiol) after Oral Administration of Fermented Red Ginseng Extract (HYFRG™) in Healthy Korean Volunteers and Rats.Research progress of Chinese herbal medicine Radix isatidis (banlangen).Compound K attenuates stromal cell-derived growth factor 1 (SDF-1)-induced migration of C6 glioma cells.Ginseng Metabolites on Cancer Chemoprevention: An Angiogenesis Link?Bioavailability of oral methylnaltrexone increases with a phosphatidylcholine-based formulation.Determination of ginsenoside compound K in human plasma by liquid chromatography-tandem mass spectrometry of lithium adducts Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes Trends in scientific publications of Chinese medicine.Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.A validated LC-MS/MS method for the simultaneous determination of 20-(S)-protopanaxatriol and its two active metabolites in rat plasma: Application to a pharmacokinetics study.Profiling the ginsenosides of three ginseng products by LC-Q-TOF/MS.The Effects of a Korean Ginseng, GINST15, on Perceptual Effort, Psychomotor Performance, and Physical Performance in Men and Women.Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer.Tissue distribution and excretion of herbal components after intravenous administration of a Chinese medicine (Shengmai injection) in rat Fecal metabolomic dataset of American ginseng-treated DSS mice: Correlation between ginseng enteric inflammation inhibition and its biological signatures

P2860

Q33910026-4578E13F-DC80-471A-A064-0165D4687EAA Q34504859-8275232E-E613-4942-ADA5-460782748BA1 Q34517159-A442840A-3E72-4BB7-9BDE-E406EBB37BDC Q34530028-BEE3AE9D-700C-4A96-B5B3-88435C7C3FC8 Q35648605-41A36A25-D91C-45D0-9FB8-99E9CE39ECA3 Q35810316-3FD5D729-48F9-49E9-90A3-BBB61C824819 Q35911467-DB7F8085-6153-44F9-9A86-33A4A630159E Q35932253-1245B123-2C00-4979-9179-91EF58F3FD23 Q36126384-FF05877C-880C-4099-B964-19743272BB22 Q36154035-5896DB86-FA1F-495E-BDFD-368B2B34C916 Q36656035-04694423-D399-4B01-A90A-D09B8F160DB9 Q36679816-33615276-E061-45B4-BD8B-DE63FBE27862 Q36743416-09D80141-C8AC-44ED-83C6-114470993B67 Q36804967-1640CB10-2C63-4162-9113-DB4F9F484DC8 Q36861245-054D303B-B2D9-4275-A11A-68B72BE1AC6C Q37144349-5CCC548D-AC5D-408C-B66C-BB8C4C6F7350 Q38124906-50146D28-F2C4-469C-B3E7-626E401A8F28 Q38413871-45E98B78-84F3-4C35-B4B8-C227B7A2C7A0 Q38700575-11CD04A1-5455-4BB2-9852-D8AD948B5583 Q39234260-572E1DA5-5A89-468D-B0EB-AF3A6E2419A5 Q41952897-550D2EAB-B616-4786-B69C-E147113689C1 Q42265763-7EA6B28E-0043-4F88-A3D3-00D4DFBB5116 Q42269777-C79EB4EE-C6A7-40BB-98D4-139CC2067B64 Q44255843-0B911199-3230-4C31-AA34-3E0504F510D9 Q46246621-39F32C19-7590-41B2-A37D-06B53B339808 Q48270389-061C5671-50E2-43C7-89D5-0953637821D9 Q50492871-A8D1D93F-690B-474A-9248-3C6BCE19A85C Q53702227-C3653022-27F0-4665-8ADD-9C515028CEAF Q55413580-97832859-7D4E-42CA-A4C4-1B497C6DD0DB Q57152993-FE3DC28D-DE0E-4209-81EE-39D7A5136A20 Q59129661-D499D742-D97B-42DB-8035-D50ABD037512

P2860

Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma

http://www.wikidata.org/entity/Q35634469

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Ultra-performance liquid chrom ...... de metabolites in human plasma

@ast

Ultra-performance liquid chrom ...... de metabolites in human plasma

@en

type

label

Ultra-performance liquid chrom ...... de metabolites in human plasma

@ast

Ultra-performance liquid chrom ...... de metabolites in human plasma

@en

prefLabel

Ultra-performance liquid chrom ...... de metabolites in human plasma

@ast

Ultra-performance liquid chrom ...... de metabolites in human plasma

@en

P1433

Q35634469-095B48BB-AD3D-4F0C-B654-043B561EFF63

P1476

Q35634469-C7E50CF4-68CA-44C1-AD0A-8C2C29E48EC7

P2093

Q35634469-0525C302-6A82-4EA1-B641-6CB068919E64

Q35634469-14B7CF79-6A91-448C-B66F-972B7E963B1F

Q35634469-187EFF5E-9E43-4A8F-BD20-5229E334B7ED

Q35634469-19F3D6DD-50A7-480F-B888-E20E1733052F

Q35634469-308AC247-3567-4618-A348-DA783BC2446A

Q35634469-4F1EFA37-E90D-4E67-90E4-36DCBDD31D9E

Q35634469-A862DCE6-A4C4-4DD7-AE3C-13F4DE193BC2

Q35634469-AC1A589A-D348-4F15-AF56-25EA9E288B71

Q35634469-C7F0B529-B203-4C62-9F50-8DB5F38318AC

Q35634469-C8DCFD24-F033-4009-AA16-7ACF0D46E8EE

P2860

Q35634469-101B9A52-F5C4-4EB8-ABA7-DBA49BDC0DEE

Q35634469-1CC35BCD-F134-437B-9A17-B34EEEE627DB

Q35634469-1D4C0212-9ED2-4121-A6DF-E2B124B66590

Q35634469-24824DAD-BCB6-435D-BDF1-C7F8297EA283

Q35634469-31804BA7-0C09-48EA-B2B4-B4A7E2AA6D10

Q35634469-3EA66982-4617-479D-A04B-CBE01D763EC7

Q35634469-49908AF2-2130-473B-95BA-98A1A3901872

Q35634469-50007395-DDF5-4433-BD64-3BC7FFA39551

Q35634469-5872EE60-4F48-44B3-A9D9-FFA6423B8581

Q35634469-6554ED34-7A25-406B-9993-CA03A5447EA5

P304

Q35634469-4BC47564-F932-4CDF-BF99-D310BA0FC6A7

P31

Q35634469-B93466B8-5AE5-4B7A-8D49-2396551DB828

P356

Q35634469-7F45515A-6746-444E-B6FE-3889A6BDC67C

P433

Q35634469-2BD11966-4050-455C-BB19-4089811B4EA9

P478

Q35634469-3E62899B-1B41-4BD6-A9A6-2C37C82638EE

P577

Q35634469-68F40702-0340-46E0-9100-EC22FB0F3486

P5875

Q35634469-879CA237-0226-4489-8B80-3E7C03D6DF71

P698

Q35634469-12CEC9BF-D498-454F-8E62-4AE97148C883

P932

Q35634469-567C41F4-F885-45F6-B2C3-E4063190D649

P356

S0192415X11009470

P1433

The American Journal of Chinese Medicine

P1476

Ultra-performance liquid chrom ...... de metabolites in human plasma

@en

P2093

Brent A Bauer

http://www.w3.org/2001/XMLSchema#string

Chong-Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Chun-Su Yuan

http://www.w3.org/2001/XMLSchema#string

Eugene B Chang

http://www.w3.org/2001/XMLSchema#string

Guang-Jian Du

http://www.w3.org/2001/XMLSchema#string

Karen E Kim

http://www.w3.org/2001/XMLSchema#string

Lian-Wen Qi

http://www.w3.org/2001/XMLSchema#string

Marc B Bissonnette

http://www.w3.org/2001/XMLSchema#string

Mark W Musch

http://www.w3.org/2001/XMLSchema#string

Ping Li

http://www.w3.org/2001/XMLSchema#string

P2860

Ginsenosides from American ginseng: chemical and pharmacological diversity

Ginseng pharmacology: multiple constituents and multiple actions

Degradation of ginsenosides in humans after oral administration

Ginsenosides chemistry, biosynthesis, analysis, and potential health effects

Mass spectrometric imaging of ginsenosides localization in Panax ginseng root.

Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir.

Herbal medicines and perioperative care.

Isolation and analysis of ginseng: advances and challenges.

Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid.

Pharmacological activity of sanchi ginseng (Panax notoginseng).

P304

1161-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1142/S0192415X11009470

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51798844

http://www.w3.org/2001/XMLSchema#string

P698

22083988

http://www.w3.org/2001/XMLSchema#string

P932

3246195

http://www.w3.org/2001/XMLSchema#string